|
Regulatory Affairs |
|
|
Seven of FDASmart ’s Training Classes |
|
|
Class Title |
Description |
1 |
What Needs To Be In A Product Submission: An FDA Reviewer’s Perspective |
A discussion of how FDA reviewers think and work and how to use that information to improve the structure and content to a submission. |
2 |
FDA’s New Guidance and Enforcement: Company Web Sites, Email & Online Advertising |
An overview of recent FDA actions affecting Internet communication about products and product risk. |
3 |
Foreign Clinical Studies: New FDA Regulations |
A review of the new 21 CFR 312.120 regulations, published in the Federal Register on April 28, 2008, about good clinical practice requirements for non-IND foreign clinical trials. |
4 |
Implementing FDA’s 2008 Guidance on the Integrated Summary of Effectiveness (ISE) |
A discussion of FDA’s new recommendations on the ISE section of an NDA or BLA submission. |
5 |
Annual Reports: SOPs for Developing Content That Meets FDA Requirements |
A discussion about annual report SOPs for drugs, biologics and devices that will produce content that meets FDA regulatory requirements. INCLUDES FIVE MODEL SOPs |
6 |
Survey of FDA Reviewer
Training: |
A discussion about how FDA reviewers are trained and how to use that information to build better submissions. |
7 |
Good Review Management: FDA’s Internal Standards and Expectations of Industry |
A discussion standards and processes meant to improve FDA performance and the quality of submissions produced by regulated industry. |
